HISA submits proposed changes to Anti-Doping and Medication Control Program rules

By: Horseracing Integrity and Safety Authority

Posted: Nov. 15, 2023

The Horseracing Integrity and Safety Authority has submitted proposed rule changes to its Anti-Doping and Medication Control Program to the Federal Trade Commission for review. Red-lined documents noting the proposed changes are available here:

Rule Series 1000: General Provisions

Rule Series 3000: Protocol

Rule Series 4000: Prohibited List

Rule Series 5000: Testing and Investigation Standards

Rule Series 6000: Laboratory Standards

Rule Series 7000: Arbitration Rules

The FTC will subsequently post the proposed rules to the Federal Register for public comment.

Until changes to the rules are approved by the FTC, the previously approved version of HISA’s ADMC rules, which took effect May 22, 2023, will remain in place. Those rules are available in full on HISA’s Regulations Page.

Similar to the proposed Racetrack Safety Program rule changes which HISA submitted to the FTC in September, the proposed changes to the ADMC rules were developed after months of dialogue with and feedback from racing participants across the country, including the HISA Horsemen’s Advisory Group.